^○Takuto Hideyama^1,2, Makiko Naito¹, Sayaka Teramoto², Tomoko Saito¹, Haruhisa Kato^1,2, Shin Kwak², Hitoshi Aizawa^1,2 (1.Department of Neurology, Tokyo Medical University, Japan, 2.Department of Molecular Neuropathogenesis, Tokyo Medical University, Japan)

^○Masanori Sawamura¹, Rie Hikawa¹, Ikuko Amano¹, Hodaka Yamakado¹, Hirofumi Yamashita², Sumio Minamiyama^1,3, Naohiro Egawa¹, Misako Kaido⁴, Yosuke Wada⁵, Makoto Urushitani³, Ryosuke Takahashi¹ (1.Kyoto University Hospital, Japan, 2.Red Cross Wakayama Medical Center, 3.Shiga University of Medical Science, 4.Sakai City Medical Center, 5.Karasuma Wada Clinic)

^○Hitoki Nanaura¹, Tomo Shiota¹, Eiichiro Mori², Kazuma Sugie¹ (1.Department of Neurology, Nara Medical University, Japan, 2.Department of Future Basic Medicine, Nara Medical University)

^○Aya Ikeda¹, Manabu Funayama¹, Mari Yoshida², Masashi Takanashi¹, Yuanzhe Li¹, Tsuyoshi Inoshita³, Kahori Shiba-fukushima³, Hongrui Meng³, Taku Amo⁴, Ikuko Aiba⁵, Yufuko Saito⁵, Naoki Atsuta⁶, Ryoichi Nakamura⁶, Genki Tohnai⁶, Jun Sone^6,10, Yuishin Izumi⁷, Ryuji Kaji⁷, Mitsuya Morita⁸, Akira Taniguchi⁹, Kenya Nishioka¹, Yuzuru Imai¹, Gen Sobue⁶, Nobutaka Hattori¹, JaCALS¹¹ (1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 3.Department of Treatment and Research in Multiple Sclerosis and Neuro-intractable Disease, Juntendo University Graduate School of Medicine, 4.Department of Applied Chemistry, National Defense Academy, 5.Department of Neurology, National Hospital Organization Higashinagoya National Hospital, 6.Department of Neurology, Nagoya University, 7.Department of Neurology, Tokushima University, 8.Division of Neurology, Department of Internal Medicine, Jichi Medical University, 9.Department of Neurology, Mie University, 10.Department of Neurology, National Hospital Organization Suzuka National Hospital, Mie, Japan., 11.JaCALS)

^○Morio Ueyama^1,3, Taro Ishiguro^3,4, Daisaku Ozawa¹, Toshihiko Sugiki⁵, Akira Ishiguro⁶, Eiichi Tokuda⁷, Takuya Konno⁸, Akihide Koyama⁸, Toshihide Takeuchi¹, Yoshiaki Furukawa⁷, Toshimichi Fujiwara⁵, Keiji Wada³, Osamu Onodera⁸, Yoshitaka Nagai^1,2,3 (1.Departments of Neurotherapeutics, Osaka University Graduate School of Medicine, Japan, 2.Departments of Neurology, Osaka University Graduate School of Medicine, 3.Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan, 4.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, 5.Laboratory of Molecular Biophysics, Institute for Protein Research, Osaka University, 6.Research Center for Micro-nano Technology, Hosei University, 7.Department of Chemistry, Keio University, 8.Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University)

^○Tomo Shiota¹, Hitoki Nanaura¹, Eiichiro Mori², Kazuma Sugie¹ (1.Department of Neurology, Nara Medical University, Japan, 2.Department of Future Basic Medicine, Nara Medical University)

^○Makiko Naito¹, Takuto Hideyama^1,2, Sayaka Teramoto², Tomoko Saito¹, Haruhisa Kato^1,2, Shin Kwak², Hitoshi Aizawa^1,2 (1.Department of Neurology, Tokyo Medical University, Japan, 2.Department of Molecular Neuropathogenesis, Tokyo Medical University)

^○Ryota Hikiami^1,2, Sumio Minamiyama^1,2, Megumi Asada^2,3, Hideki Wada², Makiko Hashi², Akemi Shodai², Ryosuke Takahashi³, Makoto Urushitani^1,2 (1.Molecular Neuroscience Research Center, Shiga University of Medical Science, Japan, 2.Department of Neurology, Shiga University of Medical Science, Japan, 3.Department of Neurology, Kyoto University Graduate School of Medicine)

^○Tetsuhiro Ueda^1,2, Nobuhiro Fujikake³, Toshihide Takeuchi¹, Satoko Sakai¹, Toshiki Mizuno², Yoshitaka Nagai^1,3 (1.Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Japan, 2.Department of Neurology, Kyoto Prefectural University of Medicine, Japan, 3.Department of Degenerative Neurological Diseases, National Center of Neurology and Psychiatry)

^○Yasuto Tanabe^1,3, Dai Watanabe², Ryosuke Takahashi³ (1.Department of Regulation of Neurocognitive Disorders, Graduate School of Medicine, Kyoto University, Japan, 2.Department of Biological Sciences, Graduate School of Medicine, Kyoto University, 3.Department of Neurology, Graduate School of Medicine, Kyoto University, Japan)

^○Shio Mitsuzawa^1,2, Naoki Suzuki¹, Tetsuya Akiyama¹, Mitsuru Ishikawa³, Jiro Kawada^4,5, Ryo Funayama⁶, Hiroaki Mitsuhashi⁷, Ayumi Nishiyama¹, Kensuke Ikeda¹, Tomomi Shijo¹, Naoko Nakamura¹, Hiroya Ono¹, Risako Ono¹, Rumiko Izumi¹, Akiyuki Ohno¹, Tadashi Nakagawa⁶, Keiko Nakayama⁶, Hitoshi Warita¹, Hideyuki Okano³, Masashi Aoki¹ (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Department of Neurology, Shodo-kai Southern Tohoku General Hospital, Japan, 3.Department of Physiology, School of Medicine, Keio University, 4.Jiksak Bioengineering Inc., 5.Institute of Industrial Science, the University of Tokyo, 6.Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, 7.Department of Applied Biochemistry, School of Engineering, Tokai University)

^○Takashi Hosaka^1,2,3, Hiroshi Tsuji¹, Makoto Terada^1,2,3, Yasushi Tomidokoro¹, Kiyotaka Nakamagoe¹, Akiko Ishii¹, Kazuhiro Ishii¹, Shin Kwak⁴, Akira Tamaoka¹ (1.Department of Neurology, Faculty of Medicine, University of Tsukuba, Japan, 2.Tsukuba University Hospital Ibaraki Western Area Medical Education Center, Japan, 3.Ibaraki Western Medical Center, Japan, 4.Department of Molecular Neuropathogenesis, Tokyo Medical University)

^○Takamasa Nukui¹, Atsushi Matsui², Hideki Niimi², Tomohiro Hayashi¹, Nobuhiro Dougu¹, Hirofumi Konishi¹, Mamoru Yamamoto¹, Ryoko Anada¹, Noriyuki Matsuda¹, Isao Kitajima², Yuji Nakatsuji¹ (1.Department of Neurology, Faculty of Medicine, University of Toyama, Japan, 2.Department of Clinical Laboratory and Molecular Pathology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama)

^○Kimie Nakamura¹, Koji Fujita², Motohisa Suzuki¹, Akiyoshi Kunugi¹, Yoshihiko Hirozane¹, Keisuke Hirai¹, Yuishin Izumi² (1.Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Co. Ltd., Kanagawa, Japan, 2.Department of Neurology, Tokushima University Hospital, Tokushima, Japan)

^○Xiao Liu, Xing Qin, Ting J. Jin, Fang F. Hu, Li Kang, Hua R. Zhang, Xia J. Dang (The First Affiliated Hospital of Xian Jiaotong University, China)